Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G8UL
|
|||
| Former ID |
DNCL001910
|
|||
| Drug Name |
Alferminogene tadenovec
|
|||
| Synonyms |
Generx (TN)
Click to Show/Hide
|
|||
| Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Phase 3 | [1] | |
| Heart disease [ICD-11: BA41-BA42; ICD-9: 390-429] | Phase 3 | [2] | ||
| Company |
Cardium Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. IDrugs. 2008 Apr;11(4):283-93. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.